Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization - A review of current strategies

Biotechnology Advances

Volumn 28, Issue 1, 2010, Pages 119-129

  Avci Adali, Meltem ^a   Ziemer, Gerhard ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Cell seeding; Endothelial progenitor cells; Endothelialization; Hemocompatibility; Restenosis; Vascular grafts

Indexed keywords

CELL SEEDING; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIALIZATION; HEMOCOMPATIBILITY; RESTENOSIS; VASCULAR GRAFTS;

BIOMATERIALS; BLOOD; ENDOTHELIAL CELLS; GRAFTS; SELF ASSEMBLY; SURFACES; TISSUE ENGINEERING;

BLOOD VESSEL PROSTHESES;

GENETIC ENGINEERING; MEDICINE; OPTIMIZATION; PHYSICOCHEMICAL PROPERTY;

ENDOTHELIUM CELL; HUMAN; INSTRUMENTATION; METHODOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; TISSUE ENGINEERING; TRANSPLANTATION; VASCULAR SURGERY;

ENDOTHELIAL CELLS; HUMANS; STEM CELLS; TISSUE ENGINEERING; TRANSPLANTS; VASCULAR SURGICAL PROCEDURES;

ANIMALIA;

EID: 71249143028     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2009.10.005     Document Type: Review

References (135)

1. Anderson S.M., Chen T.T., Iruela-Arispe M.L., and Segura T. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF. Biomaterials 30 (2009) 4618-4628
2. Aoki J., Serruys P.W., van Beusekom H., Ong A.T., McFadden E.P., Sianos G., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45 (2005) 1574-1579
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
4. Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
5. Avci-Adali M., Nolte A., Simon P., Ziemer G., and Wendel H.P. Porcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivation. J Tissue Eng Regen Med 3 (2009) 512-520
6. Berglund J.D., and Galis Z.S. Designer blood vessels and therapeutic revascularization. Br J Pharmacol 140 (2003) 627-636
7. Bhargava B., Karthikeyan G., Abizaid A.S., and Mehran R. New approaches to preventing restenosis. BMJ 327 (2003) 274-279
8. Biancone L., Cantaluppi V., Duo D., Deregibus M.C., Torre C., and Camussi G. Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 173 (2004) 5268-5274
9. Blindt R., Vogt F., Astafieva I., Fach C., Hristov M., Krott N., et al. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 47 (2006) 1786-1795
10. Breaker R.R. Natural and engineered nucleic acids as tools to explore biology. Nature 432 (2004) 838-845
11. Carmona G., Chavakis E., Koehl U., Zeiher A.M., and Dimmeler S. Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 111 (2008) 2640-2646
12. Cerchia L., Duconge F., Pestourie C., Boulay J., Aissouni Y., Gombert K., et al. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol 3 (2005) e123
13. Chandler A.B. In vitro thrombotic coagulation of the blood; a method for producing a thrombus. Lab Invest 7 (1958) 110-114
14. Chavakis E., Aicher A., Heeschen C., Sasaki K., Kaiser R., El M.N., et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201 (2005) 63-72
15. Chavakis E., Hain A., Vinci M., Carmona G., Bianchi M.E., Vajkoczy P., et al. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 100 (2007) 204-212
16. Co M., Tay E., Lee C.H., Poh K.K., Low A., Lim J., et al. Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up. Am Heart J 155 (2008) 128-132
17. Consigny P.M., Silverberg D.A., and Vitali N.J. Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty. J Vasc Interv Radiol 10 (1999) 155-163
18. de Mel A., Jell G., Stevens M.M., and Seifalian A.M. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 9 (2008) 2969-2979
19. Deutsch M., Meinhart J., Fischlein T., Preiss P., and Zilla P. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 126 (1999) 847-855
20. Ellington A.D., and Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990) 818-822
21. Fadini G.P., Baesso I., Albiero M., Sartore S., Agostini C., and Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 197 (2008) 496-503
22. Fernandez Pujol B., Lucibello F.C., Gehling U.M., Lindemann K., Weidner N., Zuzarte M.L., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65 (2000) 287-300
23. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331 (1994) 496-501
24. Foubert P., Silvestre J.S., Souttou B., Barateau V., Martin C., Ebrahimian T.G., et al. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117 (2007) 1527-1537
25. Griese D.P., Ehsan A., Melo L.G., Kong D., Zhang L., Mann M.J., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108 (2003) 2710-2715
26. Grosskreutz C.L., Anand-Apte B., Duplaa C., Quinn T.P., Terman B.I., Zetter B., et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58 (1999) 128-136
27. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93 (2003) 1023-1025
28. Guo K., Wendel H.P., Scheideler L., Ziemer G., and Scheule A.M. Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J Cell Mol Med 9 (2005) 731-736
29. Guo K.T., SchAfer R., Paul A., Gerber A., Ziemer G., and Wendel H.P. A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 24 (2006) 2220-2231
30. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
31. Harraz M., Jiao C., Hanlon H.D., Hartley R.S., and Schatteman G.C. CD34-blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
32. Heeschen C., Aicher A., Lehmann R., Fichtlscherer S., Vasa M., Urbich C., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
33. Heydarkhan-Hagvall S., Esguerra M., Helenius G., Soderberg R., Johansson B.R., and Risberg B. Production of extracellular matrix components in tissue-engineered blood vessels. Tissue Eng 12 (2006) 831-842
34. Hicke B.J., Marion C., Chang Y.F., Gould T., Lynott C.K., Parma D., et al. Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem 276 (2001) 48,644-48,654
35. Hoffmann J., Groll J., Heuts J., Rong H., Klee D., Ziemer G., et al. Blood cell and plasma protein repellent properties of star-PEG-modified surfaces. J Biomater Sci Polym Ed 17 (2006) 985-996
36. Hoffmann J., Paul A., Harwardt M., Groll J., Reeswinkel T., Klee D., et al. Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A 84 (2008) 614-621
37. Honold J., Lehmann R., Heeschen C., Walter D.H., Assmus B., Sasaki K., et al. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol 26 (2006) 2238-2243
38. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23 (2003) 1185-1189
39. Hristov M., Zernecke A., Liehn E.A., and Weber C. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 98 (2007) 274-277
40. Huang P.H., Chen Y.H., Wang C.H., Chen J.S., Tsai H.Y., Lin F.Y., et al. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29 (2009) 1179-1184
41. Hubbell J.A., Massia S.P., Desai N.P., and Drumheller P.D. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N. Y.) 9 (1991) 568-572
42. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 288-293
43. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104 (2004) 2752-2760
44. Ishizawa K., Kubo H., Yamada M., Kobayashi S., Suzuki T., Mizuno S., et al. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem Biophys Res Commun 324 (2004) 276-280
45. Jordan S.W., and Chaikof E.L. Novel thromboresistant materials. J Vasc Surg 45 Suppl A (2007) A104-A115
46. Jun H.W., Paramonov S.E., Dong H., Forraz N., McGuckin C., and Hartgerink J.D. Tuning the mechanical and bioresponsive properties of peptide-amphiphile nanofiber networks. J Biomater Sci Polym Ed 19 (2008) 665-676
47. Jun H.W., and West J. Development of a YIGSR-peptide-modified polyurethaneurea to enhance endothelialization. J Biomater Sci Polym Ed 15 (2004) 73-94
48. Jun H.W., and West J.L. Endothelialization of microporous YIGSR/PEG-modified polyurethaneurea. Tissue Eng 11 (2005) 1133-1140
49. Jun H.W., and West J.L. Modification of polyurethaneurea with PEG and YIGSR peptide to enhance endothelialization without platelet adhesion. J Biomed Mater Res B Appl Biomater 72 (2005) 131-139
50. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7 (2001) 1035-1040
51. Kim S.W., and Jacobs H. Design of nonthrombogenic polymer surfaces for blood-contacting medical devices. Blood Purif 14 (1996) 357-372
52. Kipshidze N., Dangas G., Tsapenko M., Moses J., Leon M.B., Kutryk M., et al. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 44 (2004) 733-739
53. Korbling M., Reuben J.M., Gao H., Lee B.N., Harris D.M., Cogdell D., et al. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Transfusion 46 (2006) 1795-1802
54. L'Heureux N., Dusserre N., Marini A., Garrido S., de la Fuente L., and McAllister T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat Clin Pract Cardiovasc Med 4 (2007) 389-395
55. L'Heureux N., Germain L., Labbe R., and Auger F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 17 (1993) 499-509
56. L'Heureux N., Paquet S., Labbe R., Germain L., and Auger F.A. A completely biological tissue-engineered human blood vessel. FASEB J 12 (1998) 47-56
57. Langer H., May A.E., Daub K., Heinzmann U., Lang P., Schumm M., et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 98 (2006) e2-e10
58. Langer H.F., May A.E., Vestweber D., De Boer H.C., Hatzopoulos A.K., and Gawaz M. Platelet-induced differentiation of endothelial progenitor cells. Semin Thromb Hemost 33 (2007) 136-143
59. Lee S.P., Youn S.W., Cho H.J., Li L., Kim T.Y., Yook H.S., et al. Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 114 (2006) 150-159
60. Lev E.I., Estrov Z., Aboulfatova K., Harris D., Granada J.F., Alviar C., et al. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thromb Haemost 96 (2006) 498-504
61. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
62. Ma H., Calderon T.M., Kessel T., Ashton A.W., and Berman J.W. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration. Circ Res 93 (2003) 1066-1073
63. Mallikaratchy P., Tang Z., Kwame S., Meng L., Shangguan D., and Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics 6 (2007) 2230-2238
64. Markway B.D., McCarty O.J., Marzec U.M., Courtman D.W., Hanson S.R., and Hinds M.T. Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng Part C Methods 14 (2008) 97-105
65. McCarthy J.R., and Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60 (2008) 1241-1251
66. Meinhart J.G., Deutsch M., Fischlein T., Howanietz N., Froschl A., and Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 71 (2001) S327-S331
67. Meinhart J.G., Schense J.C., Schima H., Gorlitzer M., Hubbell J.A., Deutsch M., et al. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng 11 (2005) 887-895
68. Miglionico M., Patti G., D'Ambrosio A., and Di Sciascio G. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients. Catheter Cardiovasc Interv 71 (2008) 600-604
69. Niklason L.E., Gao J., Abbott W.M., Hirschi K.K., Houser S., Marini R., et al. Functional arteries grown in vitro. Science 284 (1999) 489-493
70. Nimjee S.M., Rusconi C.P., and Sullenger B.A. Aptamers: an emerging class of therapeutics. Annu Rev Med 56 (2005) 555-583
71. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.S., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110 (2007) 3891-3899
72. Ohuchi S.P., Ohtsu T., and Nakamura Y. Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface. Biochimie 88 (2006) 897-904
73. Ong A.T., Aoki J., Kutryk M.J., and Serruys P.W. How to accelerate the endothelialization of stents. Arch Mal Coeur Vaiss 98 (2005) 123-126
74. Parenti A., Bellik L., Brogelli L., Filippi S., and Ledda F. Endogenous VEGF-A is responsible for mitogenic effects of MCP-1 on vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286 (2004) H1978-H1984
75. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
76. Peled A., Kollet O., Ponomaryov T., Petit I., Franitza S., Grabovsky V., et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95 (2000) 3289-3296
77. Pislaru S.V., Harbuzariu A., Agarwal G., Witt T., Gulati R., Sandhu N.P., et al. Magnetic forces enable rapid endothelialization of synthetic vascular grafts. Circulation 114 (2006) I314-I318
78. Pislaru S.V., Harbuzariu A., Gulati R., Witt T., Sandhu N.P., Simari R.D., et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol 48 (2006) 1839-1845
79. Powell T.M., Paul J.D., Hill J.M., Thompson M., Benjamin M., Rodrigo M., et al. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25 (2005) 296-301
80. Raddatz M.S., Dolf A., Endl E., Knolle P., Famulok M., and Mayer G. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew Chem Int Ed Engl 47 (2008) 5190-5193
81. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
82. Rohde E., Malischnik C., Thaler D., Maierhofer T., Linkesch W., Lanzer G., et al. Blood monocytes mimic endothelial progenitor cells. Stem Cells 24 (2006) 357-367
83. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
84. Rossi M.L., Zavalloni D., Gasparini G.L., Mango R., Belli G., and Presbitero P. The first report of late stent thrombosis leading to acute myocardial infarction in patient receiving the new endothelial progenitor cell capture stent. Int J Cardiol (2009) [Electronic publication ahead of print]
85. Rotmans J.I., Heyligers J.M., Verhagen H.J., Velema E., Nagtegaal M.M., de Kleijn D.P., et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112 (2005) 12-18
86. Ruoslahti E., and Pierschbacher M.D. Arg-gly-asp: a versatile cell recognition signal. Cell 44 (1986) 517-518
87. Sanders W.J., Katsumoto T.R., Bertozzi C.R., Rosen S.D., and Kiessling L.L. L-selectin-carbohydrate interactions: relevant modifications of the Lewis x trisaccharide. Biochemistry 35 (1996) 14,862-14,867
88. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
89. Schatteman G.C., Dunnwald M., and Jiao C. Biology of bone marrow-derived endothelial cell precursors. Am J Physiol Heart Circ Physiol 292 (2007) H1-H18
90. Schmedlen R.H., Elbjeirami W.M., Gobin A.S., and West J.L. Tissue engineered small-diameter vascular grafts. Clin Plast Surg 30 (2003) 507-517
91. Schmeisser A., Garlichs C.D., Zhang H., Eskafi S., Graffy C., Ludwig J., et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 49 (2001) 671-680
92. Schmeisser A., and Strasser R.H. Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J Hematother Stem Cell Res 11 (2002) 69-79
93. Schroeter M.R., Leifheit M., Sudholt P., Heida N.M., Dellas C., Rohm I., et al. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 103 (2008) 536-544
94. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331 (1994) 489-495
95. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
96. Shimizu K., Sugiyama S., Aikawa M., Fukumoto Y., Rabkin E., Libby P., et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7 (2001) 738-741
97. Shirota T., He H., Yasui H., and Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 9 (2003) 127-136
98. Silber S. Capturing circulating endothelial progenitor cells: a new concept tested in the HEALING studies. Minerva Cardioangiol 54 (2006) 1-3
99. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
100. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315-1317
101. Smith G.P., and Petrenko V.A. Phage display. Chem Rev 97 (1997) 391-410
102. Stellos K., and Gawaz M. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment. Semin Thromb Hemost 33 (2007) 159-164
103. Stellos K., Langer H., Daub K., Schoenberger T., Gauss A., Geisler T., et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 117 (2008) 206-215
104. Suuronen E.J., Veinot J.P., Wong S., Kapila V., Price J., Griffith M., et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 114 (2006) I138-I144
105. Suuronen E.J., Zhang P., Kuraitis D., Cao X., Melhuish A., McKee D., et al. An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 23 (2009) 1447-1458
106. Szmitko P.E., Fedak P.W., Weisel R.D., Stewart D.J., Kutryk M.J., and Verma S. Endothelial progenitor cells: new hope for a broken heart. Circulation 107 (2003) 3093-3100
107. Taite L.J., Yang P., Jun H.W., and West J.L. Nitric oxide-releasing polyurethane-PEG copolymer containing the YIGSR peptide promotes endothelialization with decreased platelet adhesion. J Biomed Mater Res B Appl Biomater 84 (2008) 108-116
108. Tanzi M.C. Bioactive technologies for hemocompatibility. Expert Rev Med Devices 2 (2005) 473-492
109. Tuerk C., and Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990) 505-510
110. Vartanian K.B., Kirkpatrick S.J., McCarty O.J., Vu T.Q., Hanson S.R., and Hinds M.T. Distinct extracellular matrix microenvironments of progenitor and carotid endothelial cells. J Biomed Mater Res A 91 (2009) 528-539
111. Veleva A.N., Cooper S.L., and Patterson C. Selection and initial characterization of novel peptide ligands that bind specifically to human blood outgrowth endothelial cells. Biotechnol Bioeng 98 (2007) 306-312
112. Veleva A.N., Heath D.E., Cooper S.L., and Patterson C. Selective endothelial cell attachment to peptide-modified terpolymers. Biomaterials 29 (2008) 3656-3661
113. Walenta K., Friedrich E.B., Sehnert F., Werner N., and Nickenig G. In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. Biochem Biophys Res Commun 333 (2005) 476-482
114. Walpoth B.H., and Bowlin G.L. The daunting quest for a small diameter vascular graft. Expert Rev Med Devices 2 (2005) 647-651
115. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
116. Ward M.R., Stewart D.J., and Kutryk M.J. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 70 (2007) 983-998
117. Weinberg C.B., and Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 231 (1986) 397-400
118. Wen S.J., Zhao L.M., Wang S.G., Li J.X., Chen H.Y., Liu J.L., et al. Human vascular smooth muscle cells and endothelial cells cocultured on polyglycolic acid (70/30) scaffold in tissue engineered vascular graft. Chin Med J (Engl) 120 (2007) 1331-1335
119. Wendel H.P., Avci-Adali M., and Ziemer G. Endothelial progenitor cell capture stents - hype or hope?. Int J Cardiol (2009) [Electronic publication ahead of print]
120. Wendel H.P., and Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 16 (1999) 342-350
121. Werner C., Bohm M., and Friedrich E.B. Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease. Biochem Biophys Res Commun 377 (2008) 331-336
122. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93 (2003) e17-e24
123. Wojakowski, W. and Tendera, M. Endothelial progenitor cell capture stents - practical use of cell mobilisation. E-Journal - Volume 5. 2007. Ref Type: Internet Communication.
124. Woywodt A., Bahlmann F.H., De Groot K., Haller H., and Haubitz M. Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 17 (2002) 1728-1730
125. Wu H.C., Wang T.W., Kang P.L., Tsuang Y.H., Sun J.S., and Lin F.H. Coculture of endothelial and smooth muscle cells on a collagen membrane in the development of a small-diameter vascular graft. Biomaterials 28 (2007) 1385-1392
126. Xiao Y., and Truskey G.A. Effect of receptor-ligand affinity on the strength of endothelial cell adhesion. Biophys J 71 (1996) 2869-2884
127. Yeh E.T., Zhang S., Wu H.D., Korbling M., Willerson J.T., and Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108 (2003) 2070-2073
128. Yin Y., Zhao X., Fang Y., Yu S., Zhao J., Song M., et al. SDF-1 alpha involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice. Cardiovasc Pathol (2009) [Electronic publication ahead of print]
129. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
130. Yoon C.H., Hur J., Oh I.Y., Park K.W., Kim T.Y., Shin J.H., et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 26 (2006) 1066-1072
131. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
132. Zampetaki A., Kirton J.P., and Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 78 (2008) 413-421
133. Zemani F., Silvestre J.S., Fauvel-Lafeve F., Bruel A., Vilar J., Bieche I., et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 28 (2008) 644-650
134. Zhang S.J., Zhang H., Wei Y.J., Su W.J., Liao Z.K., Hou M., et al. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 16 (2006) 577-584
135. Zilla P., Bezuidenhout D., and Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 28 (2007) 5009-5027